Penumbra, Inc. (NYSE: PEN), the world’s largest thrombectomy company, announced the U.S. Food and Drug …
New Knee Research Finds Exactech Technologies Improve Patient Outcomes
Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, …
Axogen, Inc. Announces Positive Topline Results from REPOSE, a Prospective, Randomized Clinical Trial of Axoguard Nerve Cap
Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for …
